Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (926)

« Back to Publications

Genetic Predisposition to Type 2 Diabetes and Risk of Subclinical Atherosclerosis and Cardiovascular Diseases Among 160,000 Chinese Adults.

Gan W. et al, (2019), Diabetes, 68, 2155 - 2164

Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology.

Spracklen CN. et al, (2019), Am J Hum Genet, 105, 670 - 671

Variants in the fetal genome near pro-inflammatory cytokine genes on 2q13 associate with gestational duration.

Liu X. et al, (2019), Nat Commun, 10

ZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin response.

Adeyemo AA. et al, (2019), Nat Commun, 10

Genome-wide association study of type 2 diabetes in Africa.

Chen J. et al, (2019), Diabetologia, 62, 1204 - 1211

Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls.

Flannick J. et al, (2019), Nature, 570, 71 - 76

Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by SLC29A4) and Organic Cation Transporter 1 (OCT1) (Encoded by SLC22A1) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study.

Dawed AY. et al, (2019), Diabetes Care, 42, 1027 - 1033

Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.

Warrington NM. et al, (2019), Nat Genet, 51, 804 - 814

Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors

Warrington N. et al, (2019), Nature Genetics, 51, 804 - 814

Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases.

Sanna S. et al, (2019), Nat Genet, 51, 600 - 605

Developing a network view of type 2 diabetes risk pathways through integration of genetic, genomic and functional data.

Fernández-Tajes J. et al, (2019), Genome Med, 11

The Genetic Basis of Metabolic Disease.

Barroso I. and McCarthy MI., (2019), Cell, 177, 146 - 161

Dissecting features of epigenetic variants underlying cardiometabolic risk using full-resolution epigenome profiling in regulatory elements.

Allum F. et al, (2019), Nat Commun, 10

The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects.

Middeldorp CM. et al, (2019), Eur J Epidemiol, 34, 279 - 300

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ. et al, (2019), Lancet Respir Med, 7, 227 - 238

Load More

1
2
3
4
5
6
7
...
»